BD (Becton, Dickinson and Company) announced a collaboration with Sight Diagnostics Ltd (SightDX), to introduce the ‘Parasight' Malaria Detection Platform in India.
Through this agreement BD will market the Parasight Platform in the Indian diagnostics market, adding to BD's extensive infectious disease diagnostics portfolio. The collaboration will represent the first malaria diagnostics offering from BD.
Varun Khanna, managing director, BD India and South Asia said, "Our collaboration with Sight Diagnostics is aligned with our purpose of advancing the world of health by bringing technology solutions for malaria diagnosis to India. I am confident that this strategic collaboration equips us better than ever before in disease diagnostics and will catalyse BD's role in reducing the global malaria burden."
The SightDx Parasight Malaria Detection Platform uses ground-breaking computer vision technology to analyse blood samples for malarial parasites. The technology combines innovative software algorithms, specialized optics, and a new sample preparation method, allowing patient samples to be prepared quickly, easily and reliably.
The instrument automatically analyses the sample and provides a diagnostic result within only four minutes. The device also provides information on the species of the infecting malarial parasites and provides information that may be used by clinicians to aid in determining the severity of the illness. The diagnostic information is displayed on the instrument's screen and integrates into the facility's lab information management system.